Term Name: | cabotegravir |
---|---|
Synonyms: | (3S,11aR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, CAB, cabotegravir, cabotegravirum, GSK 1265744, GSK 744, GSK-1265744, GSK-1265744A, GSK1265744, GSK1265744A, GSK744, GSK744 LA, GSK744 LAP, S-265744, S/GSK1265744 |
Definition: | A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (3S,11aR)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid with the amino group of 2,4-difluorobenzylamine. Used (as its sodium salt) for treatment of HIV-1. |
Ontology: | ChEBI [CHEBI:172944] ( EBI ) |